Advertisement

Topics

Pfizer’s Goettler On What Partners Look For In Orphan Drug Deals

04:54 EDT 1 Aug 2017 | SCRIP

Michael Goettler, Pfizer's global president, rare disease global innovative pharma business, offers tips to Korean orphan drug developers on reaching...

      

Related Stories

 

Original Article: Pfizer’s Goettler On What Partners Look For In Orphan Drug Deals

NEXT ARTICLE

More From BioPortfolio on "Pfizer’s Goettler On What Partners Look For In Orphan Drug Deals"

Quick Search
Advertisement
 

Relevant Topics

Pfizer
Pfizer is a global pharmaceutical company, the largest in world based on annual sales.  In 2009, annual sales were worth $45,448m. Pfizer spend £550m on R&D in the UK alone, and have colleagues in 180 countries. Lipitor, one of its produ...

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...